Plain-English translation of NCT07040930 on ClinicalTrials.gov ↗ · Source last updated · Translation generated · How we translate trials
Read our Rheumatoid Arthritis research guide →Phase 1 — Testing in a small group (usually 20–80 people) to find a safe dose and watch for side effects.
This is an early-stage clinical trial testing a new medication called , which is being developed to treat rheumatoid arthritis. Researchers are studying how safe this medication is, how well people tolerate it, and how the body processes it when given as multiple injections under the skin. The trial involves healthy volunteers who will receive either the new treatment or a placebo (inactive injection).
Before this medication can be tested in patients with rheumatoid arthritis, researchers need to first understand whether it is safe and how the human body responds to it. This early-stage trial helps identify any potential side effects and the right dose to use in future studies.
You likely qualify if…
You likely don't qualify if…
If you qualify and enroll, you will receive multiple injections under the skin over the course of the study — either the new medication or a placebo. The doses will be gradually increased in different groups of participants to carefully monitor safety. You will attend study visits where researchers will check your vital signs, collect blood samples, and ask about any side effects you may have experienced. The study is double-blind, meaning neither you nor the researchers know which treatment you are receiving, which helps ensure fair results.
AI-generated summary from trial data · Jun 20, 2026 · Not medical advice
China